Tracer‐specific reference tissues selection improves detection of 18F‐FDG, 18F‐florbetapir, and 18F‐flortaucipir PET SUVR changes in Alzheimer's disease
Sign Up to like & getrecommendations! Published in 2022 at "Human Brain Mapping"
DOI: 10.1002/hbm.25774
Abstract: This study sought to identify a reference tissue‐based quantification approach for improving the statistical power in detecting changes in brain glucose metabolism, amyloid, and tau deposition in Alzheimer's disease studies. A total of 794, 906,… read more here.
Keywords: reference; disease; florbetapir 18f; 18f florbetapir ... See more keywords
[18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-019-04533-y
Abstract: We evaluated myelin changes throughout the central nervous system in Multiple Sclerosis (MS) patients by using hybrid [18F]florbetapir PET-MR imaging. We included 18 relapsing-remitting MS patients and 12 healthy controls. Each subject performed a hybrid… read more here.
Keywords: multiple sclerosis; pet imaging; 18f florbetapir; florbetapir pet ... See more keywords
Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-019-04627-7
Abstract: The clinical diagnosis of pulmonary involvement in individuals with systemic AL amyloidosis remains challenging. [18F]florbetapir imaging has previously identified AL amyloid deposits in the heart and extra-cardiac organs. The aim of this study is to… read more here.
Keywords: 18f florbetapir; amyloidosis; systemic amyloidosis; quantitative 18f ... See more keywords
Classification of negative and positive 18F-florbetapir brain PET studies in subjective cognitive decline patients using a convolutional neural network
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-020-05006-3
Abstract: Visual reading of 18F-florbetapir positron emission tomography (PET) scans is used in the diagnostic process of patients with cognitive disorders for assessment of amyloid-ß (Aß) depositions. However, this can be time-consuming, and difficult in case… read more here.
Keywords: 18f florbetapir; convolutional neural; positive 18f; neural network ... See more keywords
Dual-phase 18F-florbetapir positron emission tomography in patients with primary progressive aphasia, Alzheimer's disease, and healthy controls: A preliminary study.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the Formosan Medical Association = Taiwan yi zhi"
DOI: 10.1016/j.jfma.2017.03.003
Abstract: BACKGROUND/PURPOSE To determine whether dual-phase 18F-florbetapir positron emission tomography imaging with perfusion-like and amyloid deposition information can distinguish among primary progressive aphasia (PPA), Alzheimer's disease (AD), and healthy controls (HCs). METHODS Patients diagnosed with PPA,… read more here.
Keywords: phase; phase 18f; 18f florbetapir; ppa patients ... See more keywords
Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia
Sign Up to like & getrecommendations! Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0177924
Abstract: Parkinson disease patients develop clinically significant cognitive impairment at variable times over their disease course, which is often preceded by milder deficits in memory, visuo-spatial, and executive domains. The significance of amyloid-β accumulation to these… read more here.
Keywords: cognitive impairment; 18f florbetapir; performance; parkinson disease ... See more keywords